Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
cT2N0M0
cancer registry
clinical outcomes
elective neck dissection
occult lymph node metastasis
oral cavity squamous cell carcinoma
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
03 Jan 2024
03 Jan 2024
Historique:
revised:
07
12
2023
received:
18
10
2023
accepted:
17
12
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
aheadofprint
Résumé
The current NCCN guidelines recommend considering elective neck dissection (END) for early-stage oral cavity squamous cell carcinoma (OCSCC) with a depth of invasion (DOI) exceeding 3 mm. However, this DOI threshold, determined by evaluating the occult lymph node metastatic rate, lacks robust supporting evidence regarding its impact on patient outcomes. In this nationwide study, we sought to explore the specific indications for END in patients diagnosed with OCSCC at stage cT2N0M0, as defined by the AJCC Eighth Edition staging criteria. We examined 4723 patients with cT2N0M0 OCSCC, of which 3744 underwent END and 979 were monitored through neck observation (NO). Patients who underwent END had better 5-year outcomes compared to those in the NO group. The END group had higher rates of neck control (95% vs. 84%, p < 0.0001), disease-specific survival (DSS; 87% vs. 84%, p = 0.0259), and overall survival (OS; 79% vs. 73%, p = 0.0002). Multivariable analysis identified NO, DOI ≥5.0 mm, and moderate-to-poor tumor differentiation as independent risk factors for 5-year neck control, DSS, and OS. Based on these prognostic variables, three distinct outcome subgroups were identified within the NO group. These included a low-risk subgroup (DOI <5 mm plus well-differentiated tumor), an intermediate-risk subgroup (DOI ≥5.0 mm or moderately differentiated tumor), and a high-risk subgroup (poorly differentiated tumor or DOI ≥5.0 mm plus moderately differentiated tumor). Notably, the 5-year survival outcomes (neck control/DSS/OS) for the low-risk subgroup within the NO group (97%/95%/85%, n = 251) were not inferior to those of the END group (95%/87%/79%). By implementing risk stratification within the NO group, we found that 26% (251/979) of low-risk patients achieved outcomes similar to those in the END group. Therefore, when making decisions regarding the implementation of END in patients with cT2N0M0 OCSCC, factors such as DOI and tumor differentiation should be taken into account.
Sections du résumé
BACKGROUND
BACKGROUND
The current NCCN guidelines recommend considering elective neck dissection (END) for early-stage oral cavity squamous cell carcinoma (OCSCC) with a depth of invasion (DOI) exceeding 3 mm. However, this DOI threshold, determined by evaluating the occult lymph node metastatic rate, lacks robust supporting evidence regarding its impact on patient outcomes. In this nationwide study, we sought to explore the specific indications for END in patients diagnosed with OCSCC at stage cT2N0M0, as defined by the AJCC Eighth Edition staging criteria.
METHODS
METHODS
We examined 4723 patients with cT2N0M0 OCSCC, of which 3744 underwent END and 979 were monitored through neck observation (NO).
RESULTS
RESULTS
Patients who underwent END had better 5-year outcomes compared to those in the NO group. The END group had higher rates of neck control (95% vs. 84%, p < 0.0001), disease-specific survival (DSS; 87% vs. 84%, p = 0.0259), and overall survival (OS; 79% vs. 73%, p = 0.0002). Multivariable analysis identified NO, DOI ≥5.0 mm, and moderate-to-poor tumor differentiation as independent risk factors for 5-year neck control, DSS, and OS. Based on these prognostic variables, three distinct outcome subgroups were identified within the NO group. These included a low-risk subgroup (DOI <5 mm plus well-differentiated tumor), an intermediate-risk subgroup (DOI ≥5.0 mm or moderately differentiated tumor), and a high-risk subgroup (poorly differentiated tumor or DOI ≥5.0 mm plus moderately differentiated tumor). Notably, the 5-year survival outcomes (neck control/DSS/OS) for the low-risk subgroup within the NO group (97%/95%/85%, n = 251) were not inferior to those of the END group (95%/87%/79%).
CONCLUSIONS
CONCLUSIONS
By implementing risk stratification within the NO group, we found that 26% (251/979) of low-risk patients achieved outcomes similar to those in the END group. Therefore, when making decisions regarding the implementation of END in patients with cT2N0M0 OCSCC, factors such as DOI and tumor differentiation should be taken into account.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
National comprehensive cancer network clinical practice guidelines in oncology. Head and Neck Cancers. Version I.2024, Section “PRINCIPLES OF SURGERY”, “Neck Management”, page “SURG-A 6 OF 8”. Available at: http://www.nccn.org/(Accessed on December 4, 2023.)
D'Cruz AK, Vaish R, Kapre N, et al. Head and neck disease management group. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373(6):521-529. doi:10.1056/NEJMoa1506007
Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120(7):699-702. doi:10.1001/archotol.1994.01880310005001
Massey C, Dharmarajan A, Bannuru RR, Rebeiz E. Management of N0 neck in early oral squamous cell carcinoma: a systematic review and meta-analysis. Laryngoscope. 2019;129(8):E284-E298. doi:10.1002/lary.27627
Cai H, Zhu Y, Wang C, Zhang Y, Hou J. Neck nodal recurrence and survival of clinical T1-2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129(4):296-310. doi:10.1016/j.oooo.2019.10.012
Abu-Ghanem S, Yehuda M, Carmel NN, et al. Elective neck dissection vs observation in early-stage squamous cell carcinoma of the oral tongue with no clinically apparent lymph node metastasis in the neck: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(9):857-865. doi:10.1001/jamaoto.2016.1281
Wushou A, Yibulayin F, Sheng L, Luo Y, Yang ZC. Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database. BMC Cancer. 2021;21(1):1309. doi:10.1186/s12885-021-09053-3
Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. Springer-Verlag; 2017.
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387-391. doi:10.1038/sj.bjc.6602678
Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG. Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst. 2018;110(8):803-811. doi:10.1093/jnci/djy088
American College of Surgeons. Standards for oncology registry entry. Effective for Cases Diagnosed; 2023 https://wwwfacsorg/media/vssjur3j/store_manual_2023
Chien CY, Wang CP, Lee LY, et al. Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: a nationwide study. Oral Oncol. 2023;140:106366. doi:10.1016/j.oraloncology.2023.106366
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
Borgemeester MC, van den Brekel MWM, van Tinteren H, et al. Ultrasound-guidedaspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy. Head Neck. 2008;30(11):1505-1513. doi:10.1002/hed.20903
Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultra-sonography-guided cytology: is there a role for identification of the sentinel node? Head Neck. 2002;24(3):282-289. doi:10.1002/hed.10018
Yuen AP, Ho CM, Chow TL, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009;31(6):765-772. doi:10.1002/hed.21033
Flach GB, Tenhagen M, de Bree R, et al. Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. Oral Oncol. 2013;49(2):157-164. doi:10.1016/j.oraloncology.2012.08.006
de Bree R, Takes RP, Shah JP, et al. Elective neck dissection in oral squamous cell carcinoma: past, present and future. Oral Oncol. 2019;90:87-93. doi:10.1016/j.oraloncology.2019.01.016
Lin CY, Fan KH, Lee LY, et al. Precision adjuvant therapy based on detailed pathological risk factors for resected oral cavity squamous cell carcinoma: long term outcome comparison of CGMH and NCCN guidelines. Int J Radiat Oncol Biol Phys. 2020;106(5):916-925. doi:10.1016/j.ijrobp.2019.08.058
Lee LY, Lin CY, Cheng NM, et al. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer-Comparison with pathological risk factors according to the NCCN guidelines. Cancer Med. 2021;10(19):6627-6641. doi:10.1002/cam4.4195